<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Douglas M. Ziedonis</title>
<copyright>Copyright (c) 2013  All rights reserved.</copyright>
<link>http://works.bepress.com/douglas_ziedonis</link>
<description>Recent documents in Douglas M. Ziedonis</description>
<language>en-us</language>
<lastBuildDate>Sat, 16 Feb 2013 01:45:40 PST</lastBuildDate>
<ttl>3600</ttl>


	
		
	

	
		
	

	
		
	







<item>
<title>Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence</title>
<link>http://works.bepress.com/douglas_ziedonis/108</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/108</guid>
<pubDate>Thu, 14 Feb 2013 13:11:52 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: This pilot feasibility study examined the role of genetics in laboratory-induced cocaine craving.</p>
<p>METHODS: Thirty-four African American, cocaine-depend- ent male subjects underwent a baseline assessment, cue-exposure session, and genetic analysis. Subjects were classified as either cue-reactive or nonreactive.</p>
<p>RESULTS: Among single nucleotide polymorphism markers in 13 candidate genes examined for association with cocaine cue-reactivity, two were statistically significant: GABRA2 (coding for GABA-A receptor alpha-2 subunit; rs11503014, nominal p= .001) and OPRM1 (coding for mu opioid receptor; rs2236256, nominal p= .03).</p>
<p>CONCLUSIONS: These pilot results suggest that cocaine craving shows variability among cocaine-dependent subjects, and that GABRA2 and OPRM1 polymorphisms have differential influences on cocaine cue-reactivity, warranting studies in future research.</p>

	]]>
</description>

<author>David A. Smelson et al.</author>


<category>Adult</category>

<category>African Americans</category>

<category>Cocaine-Related Disorders</category>

<category>Cues</category>

<category>Feasibility Studies</category>

<category>Genotype</category>

<category>Humans</category>

<category>Logistic Models</category>

<category>Male</category>

<category>*Polymorphism, Single Nucleotide</category>

<category>Receptors, GABA-A</category>

<category>Receptors, Opioid, mu</category>

<category>Synaptic Transmission</category>

</item>






<item>
<title>Strategies for improving perinatal depression treatment in North American outpatient obstetric settings</title>
<link>http://works.bepress.com/douglas_ziedonis/107</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/107</guid>
<pubDate>Thu, 14 Feb 2013 13:11:50 PST</pubDate>
<description>
	<![CDATA[
	<p><em>Objective</em>: To identify core barriers and facilitators to addressing perinatal depression and review clinical, programmatic, and system level interventions that may optimize perinatal depression treatment. <em></em></p>
<p><em>Method</em>: Eighty-four MEDLINE/PubMed searches were conducted using the terms perinatal depression, postpartum depression, antenatal depression, and prenatal depression in association with 21 other terms. Of 7768 papers yielded in the search, we identified 49 papers on barriers and facilitators, and 17 papers on interventions in obstetric settings aimed to engage women and/or providers in treatment. <em></em> <em></em></p>
<p><em>Results</em>: Barriers include stigma, lack of obstetric provider training, lack of resources and limited access to mental health treatment. Facilitators include validating and empowering women during interactions with health care providers, obstetric provider and staff training, standardized screening and referral processes, and improved mental health resources. <em></em> <em></em></p>
<p><em>Conclusion</em>: Specific clinical, program, and system level changes are recommended to help change the culture of obstetric care settings to optimize depression treatment.</p>

	]]>
</description>

<author>Nancy Byatt et al.</author>


<category>Depression, Postpartum</category>

<category>Perinatal Care</category>

</item>






<item>
<title>Preparing the Open Dialogue Approach for Implementation in the United States</title>
<link>http://works.bepress.com/douglas_ziedonis/106</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/106</guid>
<pubDate>Thu, 14 Feb 2013 13:11:49 PST</pubDate>
<description>
	<![CDATA[
	<p>Open Dialogue is a recovery-oriented psychosocial approach that has been found to be effective with persons in acute psychiatric crisis. Drs. Douglas Ziedonis and Mary Olson are leading a multi-disciplinary team at the University of Massachusetts Medical School / UMass Memorial Health Care to develop implementation tools (manuals, fidelity scales, etc.) that are needed to implement and evaluate the Open Dialogue approach in the United States.</p>

	]]>
</description>

<author>Douglas M. Ziedonis et al.</author>


<category>Rehabilitation/Recovery</category>

<category>Service Systems</category>

<category>Wellness</category>

</item>






<item>
<title>Patient, provider, and system-level barriers and facilitators to addressing perinatal depression</title>
<link>http://works.bepress.com/douglas_ziedonis/105</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/105</guid>
<pubDate>Tue, 27 Nov 2012 13:47:04 PST</pubDate>
<description>
	<![CDATA[
	<p><strong>Objective:</strong> To explore perinatal health care professionals’ perspectives on barriers and facilitators to addressing perinatal depression. <strong></strong></p>
<p><strong>Background:</strong> Perinatal depression is common and associated with deleterious effects on mother, foetus, child and family. Although the regular contact between mothers and perinatal health care professionals may make the obstetric setting ideal for addressing depression, barriers persist, and depression remains under-diagnosed and under-treated.</p>
<p><strong>Methods:</strong> Four 90-minute focus groups were conducted with perinatal health care professionals, including obstetric resident and attending physicians, licensed independent practitioners, nurses, patient care assistants, social workers and administrative support staff. Focus groups were transcribed, and resulting data were analysed using a grounded theory approach. <strong></strong></p>
<p><strong>Results:</strong> Participants identified patient-, provider- and system-level barriers and facilitators to addressing perinatal depression. Provider-level barriers included lack of resources, skills and confidence needed to diagnose, refer and treat perinatal depression. Limited access to mental health care and resources were identified as system-level barriers. Facilitators identified included targeted training for perinatal health care professionals’, structured screening and referral processes, and enhanced support and guidance from mental health providers. <strong></strong></p>
<p><strong>Conclusion:</strong> A complex set of interactions between women and perinatal health care professionals contributes to perinatal depression being untreated. Service gaps could be closed by addressing identified barriers through integrated obstetric and depression care and enhanced collaborations. Future intervention testing could include targeted training, improved access, and mental health provider support to empower perinatal health care professionals’ to address perinatal depression, and thereby improve delivery of depression treatment in obstetric settings.</p>

	]]>
</description>

<author>Nancy Byatt et al.</author>


<category>Depression, Postpartum</category>

<category>Perinatal Care</category>

<category>Community Mental Health Services</category>

<category>Community Mental Health Centers</category>

</item>






<item>
<title>New systems of care for substance use disorders: treatment, finance, and technology under health care reform</title>
<link>http://works.bepress.com/douglas_ziedonis/104</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/104</guid>
<pubDate>Fri, 05 Oct 2012 13:31:50 PDT</pubDate>
<description>
	<![CDATA[
	<p>This article outlined ways in which persons with addiction are currently underserved by our current health care system. However, with the coming broad scale reforms to our health care system, the access to and availability of high-quality care for substance use disorders will increase. Addiction treatments will continue to be offered through traditional substance abuse care systems, but these will be more integrated with primary care, and less separated as treatment facilities leverage opportunities to blend services, financing mechanisms, and health information systems under federally driven incentive programs. To further these reforms, vigilance will be needed by consumers, clinicians, and policy makers to assure that the unmet treatment needs of individuals with addiction are addressed. Embedded in this article are essential recommendations to facilitate the improvement of care for substance use disorders under health care reform. Ultimately, as addiction care acquires more of the "look and feel" of mainstream medicine, it is important to be mindful of preexisting trends in health care delivery overall that are reflected in recent health reform legislation. Within the world of addiction care, clinicians must move beyond their self-imposed "stigmatization" and sequestration of specialty addiction treatment. The problem for addiction care, as it becomes more "mainstream," is to not comfortably feel that general slogans like "Treatment Works," as promoted by Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment during its annual Recovery Month celebrations, will meet the expectations of stakeholders outside the specialty addiction treatment community. Rather, the problem is to show exactly how addiction treatment works, and to what extent it works-there have to be metrics showing changes in symptom level or functional outcome, changes in health care utilization, improvements in workplace attendance and productivity, or other measures. At minimum, clinicians will be required to demonstrate that their new systems of care and future clinical activity are in conformance with overall standards of "best practice" in health care.</p>

	]]>
</description>

<author>David R. Pating et al.</author>


<category>Behavior, Addictive</category>

<category>Counseling</category>

<category>Delivery of Health Care, Integrated</category>

<category>administration</category>

<category>Health Care Reform</category>

<category>Health Services Accessibility</category>

<category>Health Services Needs and Demand</category>

<category>Healthcare Disparities</category>

<category>Humans</category>

<category>Insurance Coverage</category>

<category>Insurance, Health</category>

<category>Mass Screening</category>

<category>Medical Informatics</category>

<category>Outcome Assessment (Health Care)</category>

<category>Patient-Centered Care</category>

<category>Primary Health Care</category>

<category>Substance-Related Disorders</category>

<category>United States</category>

</item>






<item>
<title>Community Mental Health Provider Reluctance to Provide Pharmacotherapy May Be a Barrier to Addressing Perinatal Depression: A Preliminary Study</title>
<link>http://works.bepress.com/douglas_ziedonis/103</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/103</guid>
<pubDate>Fri, 05 Oct 2012 13:31:48 PDT</pubDate>
<description>
	<![CDATA[
	<p>This is the first study evaluating obstetrics and gynecology (OB/Gyn) provider and staff perceptions of barriers to accessing pharmacotherapy for perinatal depression outside the obstetric setting. Four, 90 min focus groups were conducted with OB/Gyn physicians, advance practice nurses, and support and nursing staff (n = 28). Data were analyzed with a grounded theory approach. Participants perceived that community mental health providers and pharmacists often do not want to participate in pharmacotherapy for perinatal women. Participants believed the solution is training for community mental health providers in the risks and benefits of pharmacotherapy for perinatal depression and improved communication between OB/Gyn's and community mental health providers. Community mental health provider and pharmacist reluctance to provide pharmacotherapy hinders OB/Gyn's perceived ability to address perinatal depression. Community mental health provider and pharmacist training are needed to mitigate precipitous discontinuation of treatment and to improve access to pharmacotherapy for perinatal women.</p>

	]]>
</description>

<author>Nancy Byatt et al.</author>


<category>Community Mental Health Services</category>

<category>Community Mental Health Centers</category>

<category>Depression, Postpartum</category>

<category>Perinatal Care</category>

<category>Drug Therapy</category>

</item>






<item>
<title>Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies</title>
<link>http://works.bepress.com/douglas_ziedonis/102</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/102</guid>
<pubDate>Thu, 06 Sep 2012 08:37:58 PDT</pubDate>
<description>
	<![CDATA[
	<p>Treating chronic pain in the context of opioid misuse can be very challenging. This paper explores the epidemiology and potential treatments for chronic pain and opioid misuse and identifies educational and regulation changes that may reduce diversion of opioid analgesics. We cover the epidemiology of chronic pain and aberrant opioid behaviors, psychosocial influences on pain, pharmacological treatments, psychological treatments, and social treatments, as well as educational and regulatory efforts being made to reduce the diversion of prescription opioids. There are a number of ongoing challenges in treating chronic pain and opioid misuse, and more research is needed to provide strong, integrated, and empirically validated treatments to reduce opioid misuse in the context of chronic pain.<strong></strong></p>

	]]>
</description>

<author>Amy B. Wachholtz et al.</author>


<category>Chronic Pain</category>

<category>Pain</category>

<category>Pain Management</category>

<category>Analgesics, Opioid</category>

<category>Opioid-Related Disorders</category>

</item>






<item>
<title>Gender-Specific Factors Associated with Readiness to Quit Smoking among Korean Americans</title>
<link>http://works.bepress.com/douglas_ziedonis/101</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/101</guid>
<pubDate>Tue, 31 Jul 2012 12:06:53 PDT</pubDate>
<description>
	<![CDATA[
	<p><strong>Introduction:</strong> The study examined gender differences in smoking and factors associated with three stages of readiness to quit smoking (precontemplation with no quit intention in the next 6 months, contemplation with a quit intention in the next 6 months but not in the next month, and preparation with a quit intention in the next month) among Korean Americans.</p>
<p><strong>Method:</strong> The study is a telephone survey with a randomly selected sample from an online telephone directory. Inclusion criteria for participation were (a) being of 18 and older, (b) identifying self as Korean, and (c) having smoked daily for at least six months prior to the interview.</p>
<p><strong>Results:</strong> The sample comprised 70 women and 168 men with a 63.8% response rate from eligible respondents. Women were 3 years older on average than were men when they started smoking regularly (<em>t </em>= 3.5, <em>p </em>= 0.001). Women were more likely to smoke inside the house than were men (<em>X</em><sup>2 </sup>= 16.5, <em>p </em>< 0.001). Compared to women in the preparation stage, women in precontemplation and contemplation stages had decreased odds of perceiving a family norm favoring quitting and increased odds of perceiving risks of quitting. Compared to men in the preparation stage, men in precontemplation and contemplation stages had decreased odds of perceiving a family norm favoring quitting and benefits of quitting. Previous quit attempts were also a significant factor for both women and men.</p>
<p><strong>Con</strong><strong>clusions:</strong><strong> </strong>Korean American female and male smokers are similar in the aspect that they are more likely to be ready to quit when they perceive a family norm favoring quitting. However, they differ in the relationship between perceived risks and benefits of quitting and readiness to quit. These findings underscore the importance of designing gender-tailored smoking cessation interventions in addition to having culture-specific interventions with the group.</p>

	]]>
</description>

<author>Sun Kim et al.</author>


</item>






<item>
<title>Gender Differences in the Fagerström Test for Nicotine Dependence in Korean Americans</title>
<link>http://works.bepress.com/douglas_ziedonis/100</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/100</guid>
<pubDate>Thu, 19 Jul 2012 13:00:49 PDT</pubDate>
<description>
	<![CDATA[
	<p><em>Introduction:</em> This study was conducted to compare gender differences in the psychometric properties of the Fagerström Test for Nicotine Dependence (FTND). <em></em></p>
<p><em>Methods:</em> The sample comprised 334 Korean immigrants (97 women and 237 men) who reported daily smoking for the past 6 months. Item-by-item responses and exploratory factor analyses (EFA) were compared by gender. Promax rotation was selected based on findings from previous studies suggesting correlated factors. <em></em></p>
<p><em>Results:</em> Compared with men, women smoked fewer cigarettes per day, were more likely to smoke when ill in bed, and were less likely to smoke frequently in the morning. The entire sample and men within the sample had the same factor loading pattern, where three items (time to first cigarette, the cigarette most hate to give up, and smoke more frequently in the morning) were loaded on Factor 1 (morning smoking) and the remaining three items (difficult to refrain from smoking in public places, number of cigarettes smoked per day, and smoking even when ill in bed) on Factor 2 (daytime smoking). For women, however, neither the 1- nor 2-factor model fit the data well.</p>
<p><em>Conclusions:</em> For Korean American male smokers, the psychometric properties of the FTND were similar to those seen in other populations, but this was not the case with Korean American women. Clinicians may need to modify their interpretation of nicotine dependence severity if basing only on the FTND with Korean women. The FTND assesses smoking patterns which has a cultural influence and other measures of nicotine dependence should be considered.</p>

	]]>
</description>

<author>Sun Kim et al.</author>


<category>Tobacco Use Disorder</category>

<category>Asian Americans</category>

<category>Psychometrics</category>

<category>Sex Factors</category>

</item>






<item>
<title>Incorporating Tobacco Cessation Activities in ICCD Clubhouses</title>
<link>http://works.bepress.com/douglas_ziedonis/99</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/99</guid>
<pubDate>Thu, 19 Jul 2012 13:00:42 PDT</pubDate>
<description>
	<![CDATA[
	<p>The Clubhouse Model of Psychosocial Rehabilitation offers a variety of supports for members (individuals diagnosed with a Serious Mental Illness [SMI]) to help them recover and lead productive and satisfying lives. Clubhouse services include community-based employment, education, housing, outreach, advocacy, assistance with accessing health care, and social supports. Research shows that people with SMI smoke more than the general population, and are at greater risk of co-morbid health problems and premature death associated with tobacco use, obesity and inadequate health care. The purpose of this tobacco cessation project is to address tobacco use and establish health promotion interventions in clubhouses affiliated with the International Center for Clubhouse Development (ICCD).</p>
<p>Originally published as: Research You Can Use, Issue 5, 2011.</p>

	]]>
</description>

<author>Colleen E. McKay et al.</author>


<category>Rehabilitation/Recovery</category>

<category>Tobacco Addiction</category>

</item>






<item>
<title>Addressing Tobacco through Organizational Change (ATTOC)</title>
<link>http://works.bepress.com/douglas_ziedonis/98</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/98</guid>
<pubDate>Thu, 19 Jul 2012 13:00:24 PDT</pubDate>
<description>
	<![CDATA[
	<p>Describes the Addressing Tobacco through Organizational Change (ATTOC) intervention that provides services and ongoing support for agencies and organizations that are interested in learning how to initiate, improve, and or provide treatment for tobacco addiction; reduce tobacco addiction amongst employees; restrict or eliminate tobacco use on campus; and change the work environment to promote health and wellness.</p>
<p>Originally published as: Research in the Works, Issue 1, 2011.</p>

	]]>
</description>

<author>Douglas M. Ziedonis et al.</author>


<category>Tobacco Addiction</category>

</item>






<item>
<title>A Systematic Review of Smoking Cessation Intervention Studies in China</title>
<link>http://works.bepress.com/douglas_ziedonis/97</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/97</guid>
<pubDate>Tue, 27 Mar 2012 07:48:26 PDT</pubDate>
<description>
	<![CDATA[
	<p>INTRODUCTION: China has the highest number of tobacco smokers among the world's nations; however, no systematic review has been conducted of clinical trials on the efficacy of smoking cessation interventions in China. This paper summarizes findings of studies in order to compare the effect of pharmacotherapy, counseling, and Traditional Chinese Medicine (TCM) approaches on the abstinence rate.</p>
<p>METHODS: Clinical trials of smoking cessation interventions published in English or Chinese were extracted from an electronic search of PubMed and WanFang databases. The search yielded 234 studies from the PubMed and 78 studies from the WanFang.</p>
<p>RESULTS: Twenty-nine studies were included in this review. Of these, 11 (37.9%) were randomized controlled trials (RCTs) that assessed the following approaches: counseling (5 studies), TCM (3 studies), pharmacotherapy (1 study), a combination of pharmacotherapy and counseling (1 study), and physician advice (1 study). Pharmacotherapy alone or in combination with counseling generally resulted in a higher abstinence rate than counseling alone. TCM techniques such as acupuncture and ear point seed pressure yielded a much higher abstinence rate than pharmacotherapy and counseling. Findings are inconclusive, however, because most of the TCM studies were noncontrolled trials and did not provide a definition of "abstinence." Findings on the effectiveness of physician advice to quit smoking were also inconclusive.</p>
<p>Conclusions:A review of smoking cessation studies revealed that pharmacotherapy was effective in China. More RCTs of TCM approaches and physician advice are needed with long-term follow-up assessments and biochemical verification of self-reported abstinence before these approaches are adopted as evidence-based smoking cessation interventions in China.</p>

	]]>
</description>

<author>Sun S. Kim et al.</author>


<category>Smoking Cessation</category>

</item>






<item>
<title>Comorbid Pain and Opioid Addiction: Psychosocial and Pharmacological Treatments</title>
<link>http://works.bepress.com/douglas_ziedonis/96</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/96</guid>
<pubDate>Tue, 27 Mar 2012 07:48:21 PDT</pubDate>
<description>
	<![CDATA[
	<p>Treating comorbid pain (nonmalignant) and opioid addiction is a complex endeavor that requires cooperation of multi-modal treatment teams incorporating pharmacological, psychological, and social components. There are multiple barriers for patients, mental health practitioners, and physical health practitioners to provide complete treatment for this difficult treatment population. In this article, we will review which treatments have been empirically validated in this treatment population, where further research is required, and considerations for potential "best approaches" to use for patient treatment while waiting for empirically validated treatment data. We will also discuss some complementary and alternative medicine approaches that have empirical validity in treating either pain or addiction individually, though empirical validity for the treatment of comorbid pain and addiction has not been established.</p>

	]]>
</description>

<author>Amy B. Wachholtz et al.</author>


<category>Chronic Disease</category>

<category>Complementary Therapies</category>

<category>Demography</category>

<category>Humans</category>

<category>Narcotic Antagonists</category>

<category>Opioid-Related Disorders</category>

<category>Pain</category>

<category>Psychotherapy</category>

<category>Validation Studies as Topic</category>

</item>






<item>
<title>Addressing Tobacco Through Organizational Change (ATTOC) in Residential Addiction Treatment Settings</title>
<link>http://works.bepress.com/douglas_ziedonis/95</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/95</guid>
<pubDate>Tue, 27 Mar 2012 07:48:17 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Smoking prevalence among persons in addiction treatment is 3-4 times higher than in the general population. However, treatment programs often report organizational barriers to providing tobacco-related services. This study assessed the effectiveness of a six month organizational change intervention, Addressing Tobacco Through Organizational Change (ATTOC), to improve how programs address tobacco dependence.</p>
<p>METHODS: The ATTOC intervention, implemented in three residential treatment programs, included consultation, staff training, policy development, leadership support and access to nicotine replacement therapy (NRT) medication. Program staff and clients were surveyed at pre- and post-intervention, and at 6 month follow-up. The staff survey measured knowledge of the hazards of smoking, attitudes about and barriers to treating smoking, counselor self-efficacy in providing such services, and practices used to address tobacco. The client survey measured knowledge, attitudes, and tobacco-related services received. NRT use was tracked.</p>
<p>RESULTS: From pre- to post-intervention, staff beliefs became more favorable toward treating tobacco dependence (F(1, 163)=7.15, p=0.008), NRT use increased, and tobacco-related practices increased in a non-significant trend (F(1, 123)=3.66, p=0.058). Client attitudes toward treating tobacco dependence became more favorable (F(1, 235)=10.58, p=0.0013) and clients received more tobacco-related services from their program (F(1, 235)=92.86, p<0.0001) and from their counselors (F(1, 235)=61.59, p<0.0001). Most changes remained at follow-up.</p>
<p>CONCLUSIONS: The ATTOC intervention can help shift the treatment system culture and increase tobacco services in addiction treatment programs.</p>

	]]>
</description>

<author>Joseph Guydish et al.</author>


<category>Tobacco Use Disorder</category>

<category>Tobacco Use Cessation</category>

<category>Smoking Cessation</category>

<category>Residential Treatment</category>

</item>






<item>
<title>Measuring Smoking Knowledge, Attitudes and Services (S-KAS) Among Clients in Addiction Treatment</title>
<link>http://works.bepress.com/douglas_ziedonis/94</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/94</guid>
<pubDate>Tue, 27 Mar 2012 07:48:12 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Addiction treatment programs are increasingly working to address prevalent and comorbid tobacco dependence in their service populations. However at present there are few published measurement tools, with known psychometric properties, that can be used to assess client-level constructs related to tobacco dependence in addiction treatment settings. Following on previous work that developed a staff-level survey instrument, this report describes the development and measurement characteristics of the smoking knowledge, attitudes and services (S-KAS) for use with clients in addiction treatment settings.</p>
<p>METHOD: 250 clients enrolled in residential drug abuse treatment programs were surveyed. Summary statistics were used to characterize both the participants and their responses, and exploratory factor analysis (EFA) was used to examine the underlying factor structure.</p>
<p>RESULTS: Examination of the rotated factor pattern indicated that the latent structure was formed by one knowledge factor, one attitude factor, and two "service" factors reflecting program services and clinician services related to tobacco dependence. Standardized Cronbach's alpha coefficients for the four scales were, respectively, .57, .75, .82 and .82.</p>
<p>CONCLUSIONS: The proposed scales have reasonably good psychometric characteristics, although the knowledge scale leaves room for improvement, and will allow researchers to quantify client knowledge, attitudes and services regarding tobacco dependence treatment. Researchers, program administrators, and clinicians may find the S-KAS useful in changing organizational culture and clinical practices related to tobacco addiction, help in program evaluation studies, and in tracking and improving client motivation.</p>

	]]>
</description>

<author>Joseph Guydish et al.</author>


<category>Adult</category>

<category>Behavior, Addictive</category>

<category>Cross-Sectional Studies</category>

<category>Female</category>

<category>*Health Knowledge, Attitudes, Practice</category>

<category>Humans</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Smoking</category>

<category>*Substance Abuse Treatment Centers</category>

</item>






<item>
<title>Overcoming Barriers to Perinatal Depression Treatment</title>
<link>http://works.bepress.com/douglas_ziedonis/92</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/92</guid>
<pubDate>Tue, 21 Feb 2012 10:50:51 PST</pubDate>
<description>
	<![CDATA[
	<p><strong>Background</strong></p>
<p>﻿Untreated perinatal depression is common and has deleterious effects on mother, fetus/child and family  <ul> <li>Despite effective evidence-based treatment for perinatal depression, most women do not get treatment</li> </ul> <ul> <li>Obstetricians have not traditionally identified and/or responded to the mental health needs of perinatal women</li> </ul> <ul> <li>Caring and committed providers are frustrated and confused5 and mothers do not feel seen, heard or understood by their providers</li> </ul> <ul> <li>Implementing supports for perinatal women within the traditional medical model poses many challenges to mental health and obstetric providers</li> </ul></p>
<p>MotherWoman is a community-based grassroots organization dedicated to preventing and treating perinatal depression through an innovative organizational change approach, the Community-Based Perinatal Support Model (CPSM). This model includes:  <ol> <li>Peer-led support groups for perinatal women</li> <li>Organizational change interventions that include structured screening and referral, health care provider trainings and networks, and resource and referral guides</li> </ol></p>
<p><strong>Methods</strong></p>
<p>Participants</p>
<p>Four focus groups with MotherWoman clients, 3 months – 3 years postpartum who self-identified as having experienced perinatal depression or emotional crisis</p>
<p>Data collection  <ul> <li>Focus group probes targeted perceptions of the best practices to engage perinatal women in depression treatment and potential strategies for change</li> <li>Investigators met after each group to record observations and review verbatim notes</li> <li>Participants received gift cards for their participation </li> </ul></p>
<p>Data analysis  <ul> <li>Transcripts were reviewed, segmented, and coded by investigators using an iterative, constant-comparative process to identify emerging themes and recurrent patterns</li> <li>Inter-rater reliability of more than 90% was achieved by two investigators comparing randomly selected coded pages from focus group notes </li> </ul></p>
<p>Discussion  <ul> <li>Despite barriers, numerous facilitators to treatment were identified</li> </ul> <ul> <li>Supporting women’s mental health during the perinatal time period should ideally be done in both the medical setting and community</li> </ul> <ul> <li>Supporting the mental health of perinatal women is a fundamental challenge with multiple opportunities for intervention and education</li> </ul> <ul> <li>Strategies to address perinatal depression include:</li> </ul> <ol> <li>Offer training to OB/Gyn and mental health providers in the detection and screening of perinatal depression</li> <li>Prepare women for the postpartum period through psychoeducation and peer-support</li> <li>Create flexible treatment options that go beyond medication management and emphasize transition to motherhood </li> </ol></p>
<p>Results will  <ul> <li>Contribute to understanding the barriers and facilitators perinatal women experience when trying to access depression treatment</li> </ul> <ul> <li>Provide preliminary guidelines for the development of strategies to engage perinatal women in depression treatment</li> </ul> <ul> <li>Inform the development of interventions that aim to integrate the treatment of perinatal depression into medical settings</li> </ul></p>

	]]>
</description>

<author>Nancy Byatt et al.</author>


</item>






<item>
<title>MISSION-VET Treatment Manual</title>
<link>http://works.bepress.com/douglas_ziedonis/91</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/91</guid>
<pubDate>Fri, 30 Sep 2011 11:33:49 PDT</pubDate>
<description>
	<![CDATA[
	<p>Summary: Treatment manual for the Maintaining Independence and Sobriety through Systems Integration,  Outreach, and Networking (MISSION) treatment approach, which was adapted  specifically for Veterans (MISSION-VET). MISSION-VET, a flexible,  integrated, time-limited, yet assertive service delivery platform was  designed specifically to provide direct treatment, ongoing support, and  care coordination to homeless Veterans suffering from co-occurring  disorders transitioning and/or adjusting to independent living in the  community. This audience for this manual is case managers and peer support specialists.</p>
<p>Citation: Smelson DA, Sawh L, Kane V, Kuhn J, Zeidonis DM. (2011). <em>The MISSION-VET Treatment Manual. </em>Bedford, Mass.: Veterans Health Administration.  <a href="http://www.va.gov/HOMELESS/docs/Center/MISSION_Veteran_Treatment_Manual.pdf">Link to book on publisher's website</a></p>

	]]>
</description>

<author>David A. Smelson et al.</author>


<category>Veterans</category>

<category>Veterans Health</category>

<category>Mental Health Services</category>

</item>






<item>
<title>The effect of removing cost as a barrier to treatment initiation with outpatient tobacco dependence clinics among emergency department patients</title>
<link>http://works.bepress.com/douglas_ziedonis/90</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/90</guid>
<pubDate>Thu, 30 Jun 2011 08:01:46 PDT</pubDate>
<description>
	<![CDATA[
	<p>Objectives:  The campaign against tobacco addiction and smoking continues to play an important role in public health. However, referrals to outpatient tobacco cessation programs by emergency physicians are rarely pursued by patients following discharge. This study explored cost as a barrier to follow-up.</p>
<p>Methods: The study was performed at a large urban hospital emergency department (ED) in Camden, New Jersey. Enrollment included adults who reported tobacco use in the past 30 days. Study participants were informed about a "Stop Smoking Clinic" affiliated with the hospital and, depending on enrollment date, cost of treatment was advertised as $150 (standard fee), $20 (reduced fee), or $0 (no fee). Monitoring of patient inquiries and visits to the clinic was performed for 6 months following enrollment of the last study subject.</p>
<p>Results:  The analyzed sample consisted of 577 tobacco users. There were no statistically significant demographic differences between treatment groups (p > 0.05). Two-hundred forty-seven (43%) participants reported "very much" interest in smoking cessation. However, there was no significant difference in initiating treatment with the Stop Smoking Clinic across experimental condition. Only a single subject, enrolled in the no-fee phase, initiated treatment with the clinic.</p>
<p>Conclusions:  Cost is unlikely to be the only barrier to pursing outpatient tobacco treatment after an ED visit. Further research is needed to determine the critical components of counseling and referral that maximize postdischarge treatment initiation.  (c) 2011 by the Society for Academic Emergency Medicine</p>

	]]>
</description>

<author>Deepak K. Ozhathil et al.</author>


<category>*Directive Counseling</category>

<category>*Emergency Service, Hospital</category>

<category>Referral and Consultation</category>

<category>Physician-Patient Relations</category>

<category>Smoking Cessation</category>

</item>






<item>
<title>A Brief Treatment Engagement Intervention for Individuals with Co-occurring Mental Illness and Substance Use Disorders: Results of a Randomized Clinical Trial</title>
<link>http://works.bepress.com/douglas_ziedonis/89</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/89</guid>
<pubDate>Fri, 25 Mar 2011 08:51:07 PDT</pubDate>
<description>
	<![CDATA[
	<p>Study objectives were to evaluate a brief intervention designed to facilitate outpatient engagement following an inpatient psychiatric stay for individuals with mental illness and substance use. A total of 102 veterans were randomly assigned to one of two conditions: (1) Time Limited Care-Coordination (TLC), an eight-week co-occurring disorders intervention or (2) a matched attention (MA) control condition in the form of health education sessions. Both groups also received treatment as usual in inpatient and outpatient settings. Sixty-nine percent of TLC participants attended an outpatient appointment within 14 days of discharge, compared to only 33% of MA participants (P < 0.01). TLC participants were also more likely to be engaged in outpatient services at the end of the intervention period (44 vs. 22%, P < 0.01). This study provided evidence that an eight-week intervention could improve treatment engagement. Research is currently underway to examine impact of TLC intervention beyond the 8 week study period.</p>

	]]>
</description>

<author>David A. Smelson et al.</author>


<category>Mental Disorders</category>

<category>Substance-Related Disorders</category>

<category>Inpatients</category>

<category>Outpatients</category>

<category>Treatment Outcome</category>

</item>






<item>
<title>Intentions to quit smoking: causal attribution, perceived illness severity, and event-related fear during an acute health event</title>
<link>http://works.bepress.com/douglas_ziedonis/88</link>
<guid isPermaLink="true">http://works.bepress.com/douglas_ziedonis/88</guid>
<pubDate>Fri, 25 Mar 2011 08:51:03 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Experiencing a serious consequence related to one's health behavior may motivate behavior change. PURPOSE: This study sought to examine how causal attribution, perceived illness severity, and fear secondary to an acute health event relate to intentions to quit smoking.</p>
<p>METHODS: Using a cross-sectional survey design, adult emergency department patients who smoked provided demographic data and ratings of nicotine dependence, causal attribution, perceived illness severity, event-related fear, and intentions to quit smoking.</p>
<p>RESULTS: A linear regression analysis was used to examine the relations between the independent variables and quit intentions. We enrolled 186 participants. After adjusting for nicotine dependence, smoking-related causal attribution and event-related fear were associated with intentions to quit (beta = 0.26, p < 0.01 and beta = 0.21, p < 0.01, respectively). Perceived illness severity was correlated with event-related fear (r = 0.46, p < 0.001) but was not associated with intentions to quit (beta = -0.08, p = 0.32).</p>
<p>CONCLUSION: While causal attribution and event-related fear were modestly associated with quit intentions, perceived illness severity was not. Longitudinal studies are needed to better explicate the relation between these variables and behavior change milestones.</p>

	]]>
</description>

<author>Edwin D. Boudreaux et al.</author>


<category>Smoking Cessation</category>

<category>Fear</category>

<category>Intention</category>

<category>Smoking</category>

<category>Tobacco Use Disorder</category>

</item>





</channel>
</rss>
